Search Results - M. Rassool
- Showing 1 - 2 results of 2
-
1
A phase IIb, open-label, randomized controlled dose ranging multi-centre trial to evaluate the safety, tolerability, pharmacokinetics and exposure-response relationship of differen... by A Dierig, M Hoelscher, S Schultz, L Hoffmann, A Jarchow-MacDonald, EM Svensson, L Te Brake, R Aarnoutse, M Boeree, TD McHugh, LM Wildner, X Gong, PPJ Phillips, LT Minja, N Ntinginya, S Mpagama, A Liyoyo, RS Wallis, M Sebe, FA Mhimbira, B Mbeya, M Rassool, L Geiter, YL Cho, N Heinrich
Published in Trials (2023-06-01)Get full text
Article -
2
panTB-HM: a multi-arm clinical trial of a pan-TB regimen targeting both host and microbe by D. Mudzengi, S. Mashatole, Q. Xiang, C. Adrion, N. Glover, T. Ngwanto, J. Mdluli, S. Boniface, M. Rassool, B. Matome, L. Paramo, E. Svensson, A. Fasanmi, S. Angelo, M. Moyo, C. Marx, C. Khosa, L. Mokaba, N. Mofokeng, J. Lalashowi, C. Nacy, S. Charalambous, E. Fumane, V. Maphossa, T. Beattie, W. Brumskine, C. Venter, D. Mapamba, N. Heinrich, S. Rajaram, S. Kooverjee, L. Botha, M. Nell, A. Easton, S. Foraida, Robin Mark Warren, Issa Sabi, N. Ntinginya, R. S. Wallis, panTB-HM Consortium
Published in Trials (2026-02-01)Get full text
Article
